Free Trial
NASDAQ:LVGO

Livongo Health (LVGO) Stock Price, News & Analysis

→ The Gold Grab of the Century (From Colonial Metals) (Ad)
Free LVGO Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$139.77
▼
$139.77
50-Day Range
$136.67
▼
$148.08
52-Week Range
$18.76
▼
$151.05
Volume
N/A
Average Volume
3.04 million shs
Market Capitalization
$14.20 billion
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock Analysis
Stock Analysis
LVGO stock logo

About Livongo Health Stock (NASDAQ:LVGO)

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.

LVGO Stock News Headlines

June 20, 2023 | news.yahoo.com
Diabetes management startup Clivi wants to be ‘Livongo of Latin America’
August 9, 2022 | tmcnet.com
Salvo Health Secures $10.5 Million in Seed Funding To Scale Virtual Health Clinic for Chronic Conditions
April 28, 2024 | Altimetry (Ad)
Urgent Nvidia Warning
Could Steve Job's 'Final Prophecy' Make You Rich? Just before he died, Steve Jobs issued a "Final Prophecy" that's now coming true... and making some people rich. In one recent 90-day stretch, 50 companies related to Jobs' "Final Prophecy" soared by 100% or more. What was Steve Jobs' last big prediction, and how can you get in on it? Professor Joel Litman explains everything... including the surprising group of stocks moving higher, and his No. 1 favorite stock in this space.
August 1, 2022 | investing.com
Down 87%, Could Teladoc Health Stock Actually Be A Buy?
May 31, 2022 | bizjournals.com
Homeward partners with Rite Aid to deliver rural health care
October 29, 2021 | apnews.com
Dr. Kimon Angelides Announces Latest Venture, FemTec Health, a Health Sciences Company with a Mission to Transform Women’s Healthcare
See More Headlines
Receive LVGO Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Livongo Health and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/28/2020
Today
4/28/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Computer Programming, Data Processing, & Other Computer Related
Sub-Industry
N/A
Current Symbol
NASDAQ:LVGO
CUSIP
N/A
CIK
N/A
Web
www.livongo.com
Phone
866-435-5643
Fax
N/A
Employees
471
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
($1.01)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-55,270,000.00
Net Margins
-12.20%
Pretax Margin
N/A
Return on Equity
0.29%
Return on Assets
0.21%

Debt

Debt-to-Equity Ratio
0.69
Current Ratio
19.88
Quick Ratio
19.51

Sales & Book Value

Annual Sales
$170.20 million
Price / Sales
83.42
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$5.37 per share
Price / Book
26.03

Miscellaneous

Outstanding Shares
101,585,000
Free Float
N/A
Market Cap
$14.20 billion
Optionable
Not Optionable
Beta
1.81
20 Stocks to Sell Now Cover
20 Stocks to Sell Now

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report

LVGO Stock Analysis - Frequently Asked Questions

How were Livongo Health's earnings last quarter?

Livongo Health, Inc. (NASDAQ:LVGO) issued its quarterly earnings data on Wednesday, October, 28th. The company reported $0.16 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.05 by $0.11. The firm earned $106.10 million during the quarter, compared to analysts' expectations of $95.57 million. Livongo Health had a negative net margin of 12.20% and a positive trailing twelve-month return on equity of 0.29%.

What other stocks do shareholders of Livongo Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Livongo Health investors own include NVIDIA (NVDA), Teladoc Health (TDOC), DocuSign (DOCU), Tesla (TSLA), Block (SQ), PayPal (PYPL), Salesforce (CRM), Zoom Video Communications (ZM), CrowdStrike (CRWD) and Fastly (FSLY).

When did Livongo Health IPO?

Livongo Health (LVGO) raised $230 million in an initial public offering on Thursday, July 25th 2019. The company issued 10,700,000 shares at $20.00-$23.00 per share. Morgan Stanley, Goldman Sachs and J.P. Morgan served as the underwriters for the IPO and Piper Jaffray, SVB Leerink, Canaccord Genuity, KeyBanc Capital Markets and Needham & Company were co-managers.

This page (NASDAQ:LVGO) was last updated on 4/28/2024 by MarketBeat.com Staff

From Our Partners
Conflict In Israel Sends Gold Soaring ???? Here’s How To Get Your Share
Colonial Metals
This AI Trade Machine Made 1,729%* (With 89% Wins)
Prosper Trading Academy
He Is Giving Away Bitcoin
Crypto Swap Profits
The A.I. story nobody is telling you (Read ASAP)
TradeSmith
Bitcoin Rockets To Record High But Buy THIS Instead
Paradigm Press
Why Big Pharma is Investing Billions in This Biotech
Behind the Markets
Jeff Bezos Just Humiliated Elon Musk
InvestorPlace
The only accurate crypto trading system I know …
Weiss Ratings